A systematic review published in 2023 reported that, among SCAD patients who underwent genetic testing, 20% harbored mutations in COL genes, 13.7% in TLN1, and 8.4% in TSR1 [18]. The gene discussed is TLN1; the disease is spontaneous coronary artery dissection.